Next report date
Report period
Q1 2024
EPS estimate
−0.19CHF
Revenue estimate
77.24 MCHF
−190.73 MCHF
279.03 MCHF
198.73 M
Om BioCryst Pharmaceuticals, Inc.
Sektor
Bransch
VD
Jon P. Stonehouse
Webbplats
Huvudkvarter
Durham
Employees (FY)
536
Grundat
1986
FIGI
BBG00LVDC0P9
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
